Streetbeat News

Analyst Ratings

HCP

Piper Sandler analyst James Fish has reiterated a Neutral rating on HashiCorp (NASDAQ:HCP) and increased the price target from $22 to $25.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 2:25 pm

ALTM

Piper Sandler analyst Charles Neivert has maintained an Underweight rating on Arcadium Lithium (NYSE:ALTM) but raised the price target from $4.5 to $5.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 2:23 pm

EHAB

Jefferies analyst Brian Tanquilut maintains a Buy rating on Enhabit (NYSE:EHAB) but lowers the price target from $15 to $14.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 2:22 pm

BLK

CABA

GNRC

MARA

POWL

PTLO

RF

VICI

Jim Cramer shared his views on several stocks on CNBC's 'Mad Money Lightning Round'. He recommended holding onto Regions Financial Corporation (RF), praised BlackRock, Inc. (BLK) for its financial significance, and expressed caution about VICI Properties Inc. (VICI) due to its dicey nature despite good management. Cramer advised buying a bitcoin ETF over Marathon Digital Holdings, Inc. (MARA), supported Generac Holdings Inc. (GNRC) in a low-interest environment, and recognized Powell Industries, Inc. (POWL) as a solid company. He criticized Portillo's Inc. (PTLO) for being overvalued and lacking in earnings, while showing optimism for Cabaletta Bio, Inc. (CABA) due to its potential in T-cell immunity.

Portfolio Pulse from Avi Kapoor

March 06, 2024 | 2:20 pm

SYBT

Piper Sandler analyst Casey Orr Whitman reinstates Stock Yards Bancorp (NASDAQ:SYBT) with a Neutral rating and sets a price target of $52.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 2:19 pm

LFST

Jefferies analyst Brian Tanquilut has maintained a Buy rating on LifeStance Health Group (LFST) and increased the price target from $8 to $9.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 2:18 pm

ALHC

Piper Sandler analyst Jessica Tassan downgraded Alignment Healthcare (ALHC) from Overweight to Neutral and reduced the price target from $12 to $6.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 2:17 pm

MD

Jefferies analyst Brian Tanquilut maintains a Hold rating on Pediatrix Medical Group (MD) and lowers the price target from $10 to $9.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 2:15 pm

TGT

Deutsche Bank analyst Paul Trussell upgraded Target Corporation (NYSE:TGT) from Hold to Buy and increased the price target from $149 to $206.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 2:14 pm

NIO

Jefferies analyst Xiaoyi Lei maintains a Hold rating on NIO Inc. (NYSE:NIO) and lowers the price target from $8.3 to $5.9.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 2:12 pm